TY  - GEN
AU  - Milosevic,Michael F
AU  - Townsley,Carol A
AU  - Chaudary,Naz
AU  - Clarke,Blaise
AU  - Pintilie,Melania
AU  - Fan,Stacy
AU  - Glicksman,Rachel
AU  - Haider,Masoom
AU  - Kim,Sunmo
AU  - MacKay,Helen
AU  - Yeung,Ivan
AU  - Hill,Richard P
AU  - Fyles,Anthony
AU  - Oza,Amit M
TI  - Sorafenib Increases Tumor Hypoxia in Cervical Cancer Patients Treated With Radiation Therapy: Results of a Phase 1 Clinical Study
SN  - 1879-355X
PY  - 2016///0427
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Biomarkers
KW  - Brachytherapy
KW  - methods
KW  - Carcinoma, Squamous Cell
KW  - blood supply
KW  - Cell Hypoxia
KW  - Chemoradiotherapy
KW  - Cisplatin
KW  - Drug Administration Schedule
KW  - Early Termination of Clinical Trials
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Niacinamide
KW  - Oxygen
KW  - metabolism
KW  - Partial Pressure
KW  - Phenylurea Compounds
KW  - Radiation Tolerance
KW  - drug effects
KW  - Sorafenib
KW  - Time Factors
KW  - Tumor Burden
KW  - Uterine Cervical Neoplasms
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ijrobp.2015.09.009
ER  -